SUMATRIPTAN
- Product NDC
- 64380-740
- 11-digit product format
- 643800740
- Labeler code
- 64380
- Product ID
- 64380-740_e2353e1b-62d5-4744-a81c-6e46f82d4d38
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- sumatriptan
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Strides Pharma Science Limited
- Application
- ANDA090314
- Marketing category
- ANDA
- Marketing start
- 2026-03-16
- Substance
- SUMATRIPTAN SUCCINATE
- Active strength
- 6 mg/.5mL
- Pharmacologic classes
- Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- SUMATRIPTAN
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| SUMATRIPTAN SUCCINATE | 6 mg/.5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | J8BDZ68989 |
| Rxcui | 1657151 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 64380-740-01 | SUMATRIPTAN | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 4 |
| 64380-740-01 | SUMATRIPTAN | 0.5 mL in 1 SYRINGE | INJECTION, SOLUTION | 0.5 | | 4 |
| 64380-740-02 | SUMATRIPTAN | 0.5 mL in 1 SYRINGE | INJECTION, SOLUTION | 0.5 | | 4 |
| 64380-740-02 | SUMATRIPTAN | 2 in 1 CARTON | INJECTION, SOLUTION | 2 | | 4 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 64380-740-01 | 64380074001 | 1 SYRINGE in 1 CARTON (64380-740-01) / .5 mL in 1 SYRINGE | 1 syringe | 2026-03-16 | No | No | Current |
| 64380-740-02 | 64380074002 | 2 SYRINGE in 1 CARTON (64380-740-02) / .5 mL in 1 SYRINGE | 2 syringe | 2026-03-16 | No | No | Current |